Custom Portfolio Group »

SPDR S&P Pharmaceuticals shares owned by Custom Portfolio Group

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Custom Portfolio Group from 13F filings

Historical chart of Custom Portfolio Group investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Custom Portfolio Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Custom Portfolio Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $16k 410 39.78
2024-03-31 $18k 410 43.13
2023-12-31 $17k 410 41.62

More positions owned by Custom Portfolio Group

iShares 0-3 Month Treasury Bond ETF Etf (SGOV)
Vanguard S&P 500 Index Fund ETF Etf
Schwab US Broad Market ETF Etf (SCHB)
iShares Gold Trust ETF Etf (IAU)
Vanguard Short-Term Treasury Index Fund ETF Etf (VGSH)
SPDR Gold Shares ETF Etf (GLD)
Vanguard Energy Index Fund ETF Etf (VDE)
Vanguard Inter-Term Treasury Bond Index ETF Etf (VGIT)
iShares Silver Trust ETF Etf (SLV)
iShares Emerging Markets Dividend ETF Etf (DVYE)
iShares Asia/Pacific Dividend ETF Etf (DVYA)
iShares Intl Select Dividend ETF Etf (IDV)
Vanguard US Multifactor Fund ETF Etf (VFMF)
Microsoft Corp Common Stock (MSFT)
ConocoPhillips Common Stock (COP)

View all positions for Custom Portfolio Group

Top funds holding SPDR S&P Pharmaceuticals

Clal Insurance Enterprises Holdings
Bank of America Corporation
Equitable Holdings
Bnp Paribas Arbitrage, Snc
Morgan Stanley
LPL Financial
First Citizens Bank & Trust
Wells Fargo & Company
Envestnet Portfolio Solutions
Susquehanna International
Citigroup
Rockport Wealth
Wharton Business Group
Goldman Sachs Group
MAI Wealth Advisors

View all funds holding SPDR S&P Pharmaceuticals